Zebras, goats, CEO keynotes...oh my! 🦒✨We're having a blast at #EPICUGM2024 and are inspired by the innovators working in the genomic data space to empower people's healthcare journeys. Stop by our booth and say hello! #Natera #Aura #UGM
Natera
Biotechnology Research
Austin, Texas 126,263 followers
We are a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health.
Über uns
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment. Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients. #TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes. https://www.natera.com/privacy/
- Website
-
http://www.natera.com
External link for Natera
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 1.001-5.000 Mitarbeiter
- Hauptsitz
- Austin, Texas
- Typ
- Öffentliches Unternehmen
- Gegründet
- 2004
- Spezialitäten
- Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
Standorte
-
Primäre
13011A McCallen Pass
Austin, Texas 78753, US
-
201 Industrial Road, Suite 410
San Carlos, CA 94070, US
Employees at Natera
Aktualisierungen
-
We are pleased to share that our extraction labs have achieved My Green Lab Certification, underscoring our dedication to sustainability. Our Austin lab proudly earned Silver Certification, while our San Carlos lab achieved the prestigious Platinum Certification. This achievement reflects the incredible hard work and dedication of our #Natera team and aligns with our 2025 ESG goals. Kudos and thank you to everyone involved! #GreenLabs #MyGreenLabCertification
-
“As we move forward, Natera remains dedicated to our mission and core values. We are fortunate to participate in the healthcare journeys of millions of patients and their families, and we will continue to drive positive change on ESG matters to create a healthier, more sustainable future for all.” - Steve Chapman, CEO for Natera We're proud to share the ways we have committed to sustainability, ethical practices and positive social impact in the past year. Here are some key highlights from our 2023 Environmental, Social, and Governance (ESG) report: 🌍 Environmental Stewardship: We’ve reduced our Scope 1 & 2 emissions by 11% since 2021 by implementing energy efficiency initiatives in our labs, as well as rolling out electric vehicles in our fleet. We have also achieved our 2025 supplier engagement goal, and have eliminated more than 250K pounds of material from our test kits. 💙 Empowering our people, patients and communities: In 2023, we served 1.7M patients, contributed more than 6200 volunteer hours to our local communities and 84% of employees indicated that they are proud to work for Natera. 📊 Governance Excellence: Enhanced corporate governance practices, including stronger board oversight, improved stakeholder engagement and robust ethical guidelines. This milestone is a testament to the collective efforts of our dedicated team, partners and stakeholders. We invite you to explore our latest ESG report and join us in our commitment to driving positive change. View the full report: https://lnkd.in/gsGAZgj3 #Natera #ESG #CorporateResponsibility #EnvironmentalImpact #TeamNatera
-
Today we commemorate Juneteenth, the day in June 1865 when Union soldiers arrived in Galveston, TX with news that the Civil War was over and enslaved people were free. This day symbolizes freedom, resilience, and the ongoing pursuit of equality. Learn more: https://ow.ly/K3Pe50SlFVS
-
Introducing Prospera Heart with Donor Quantity Score (DQS). DQS is now included with the Prospera Heart Transplant Assessment test for a clearer picture of transplant rejection risk. See the full announcement below.
We’re excited to announce the launch of Prospera Heart with Donor Quantity Score (DQS), further enhancing Prospera’s ability to detect rejection in heart transplant patients. “Over the last two decades, Natera has pioneered cfDNA testing across women’s health, oncology, and transplant medicine,” said Michael Olymbios, M.D., medical director of heart transplant at Natera. “Our extensive experience with cfDNA and Natera’s culture of continuous innovation drove us to further refine Prospera Heart by introducing this two-threshold algorithm to better serve the transplant community.” DQS technique is unique to Natera improving detection of both acute cellular rejection and antibody-mediated rejection. Read the full announcement here: https://ow.ly/5g3Z50SjXBG #Natera #TransplantInnovation #cfDNA #DQS
Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
natera.com
-
Whether you’re a dad, stepdad, grandpa, or someone who steps into the fatherly role, your love, guidance, and support make a world of difference. We also know that this day can be difficult for many people, and we extend our deepest sympathy to you during this time. We wish all the dads and father figures a fantastic Father's Day! 💙from Team Natera.
-
-
#TeamNatera had a busy season with presences at some of the largest medical conferences around the country. ✈️🤝📈 🤰 At the ACOG Annual Meeting in San Francisco, we presented a groundbreaking study on Fetal RhD NIPT and hosted a packed product theater at the largest international meeting for obstetricians and gynecologists. 🔬 Our team showcased key insights on the benefits of genetic testing in nephrology at the NKF Spring Clinical Meeting in Philadelphia with two well-received posters and hosting our first event at NKF. 🧬 Along with our collaborators, we presented over a dozen abstracts in multiple tumor types at the ASCO Annual Meeting in Chicago, highlighting Signatera and Empower data while connecting with industry leaders with a shared vision to shift the paradigm of cancer care. 👩⚕️ At the ATC in Philadelphia, we presented 18 abstracts on Prospera data, highlighting advancements in heart, lung, kidney, and multi-organ transplantation, with two posters receiving “best of show” recognition. Thanks to all who attended, presented, and collaborated with us at these events! We’re thrilled to present our latest data among the nation’s leaders in the oncology, transplant, organ and reproductive health industries. #MedicalInnovation #Natera #ATC2024Philly #ASCO24 #ACOG2024 #SCM24 American College of Obstetricians and Gynecologists (ACOG) National Kidney Foundation ASCO American Transplant Congress (ATC)
-
-
PRIDE HISTORY 🏳️🌈 The first gay pride parade was held in New York City one year after the Stonewall riots, a series of riots for gay liberation that took place over several days beginning on June 28, 1969. Since then, communities have come together all over the world to celebrate June as Pride Month. Did you know? 🌈 Artist Gilbert Baker designed the rainbow flag for the 1978 San Francisco’s Gay Freedom Celebration. Of the design, Baker said, “We needed something to express our joy, our beauty, our power. And the rainbow did that.” #TeamNatera is proud to support The Trevor Project, the world’s largest suicide prevention and mental health organization for LGBTQ+ young people. As part of our Charitable Donation Matching Program, we will match eligible donations made by Naterans to this organization during this month and beyond. Learn more about The Trevor Project: https://ow.ly/X9io50SaXR4
-
Congratulations to the Natera Organ Health team on this best of show recognition! #ATC2024Philly #Natera #HeartTransplant
Exciting news out of #ATC2024Philly! Natera's poster titled Extremely Elevated dd-cfDNA Post Heart Transplant: A Critical Result Case Review Series, presented by Sandra Carey, PhD, associate medical director at #Natera, received best of show! 🏆 ATC attendees can visit poster 70 to hear Dr. Carey present these findings today at 2:30 PM ET. Congratulations to all involved! 👏 See the full details of our 18 presentations and special events at the American Transplant Congress (ATC): https://ow.ly/C39a50S7i3R
-
-
We recognize National Cancer Survivors Day today, June 2, and Cancer Survivors Month in June. This period is a celebration of life, an inspiration to those recently diagnosed and an opportunity for community outreach. We hope you take time to reflect and find moments of joy, whether you are celebrating your own cancer survivorship or a loved one’s. At Natera, we continue to support the journeys of so many cancer survivors, including Naterans and their friends and families, and we acknowledge their resilience and strength. For more information on how communities are celebrating and how you can get involved, visit the National Cancer Survivors Day Foundation, Inc. website. https://ow.ly/Posw50S5El8 #CancerSurvivors #NCSD2024
-
Verbundene Seiten
Ähnliche Seiten
Jobs durchsuchen
Aktie
NTRA
NASDAQ
20 Minuten Verzögerung
$118.81
-1.46 (-1.214%)
- Öffnen Sie
- 119.79
- Niedrig
- 117.65
- Hoch
- 120.666
Daten von Refinitiv
Siehe mehr Informationen aufFinanzierung
Letzte Runde
Eigenkapital nach dem IPOUS$ 250.0M